Stroke Trial, Recruiting NCT05504941 Sponsor: University Hospital, Basel, Switzerland Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05504941
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a sudden, non-trauma-related bleed in the brain, confirmed by a CT scan (without contrast dye).
  • People where the brain imaging procedure (called a cerebral DSA, a detailed X-ray of blood vessels) can be started within 3 hours of symptoms first appearing.
  • People whose treating doctor has agreed to perform the brain imaging procedure.
  • People (or their legal representative) who have given signed consent to participate, or where emergency consent procedures apply because the person is unable to consent at the time.

Who may not be able to join:

  • People whose treating doctor believes the bleed was most likely caused by a burst aneurysm, an abnormal tangle of blood vessels (arteriovenous malformation), or a condition called amyloid angiopathy.
  • People who need urgent surgery or another time-sensitive procedure.
  • People who are currently pregnant (a negative pregnancy test is required for anyone who could potentially be pregnant).
  • People who have a medical reason they cannot receive iodine-based contrast dye, which is used during the imaging procedure.
  • People known to have severely reduced kidney function (specifically, a kidney filtration rate below 30 ml/min).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marios-Nikos Psychogios, Prof Dr, Department of Neuroradiology, University Hospital Basel

Phone: +41 61 328 79 48

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Basel, Switzerland
Registry
ClinicalTrials.gov
Start date
25 October 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Presence of a treatment target for a potential endovascular therapy (binary endpoint: yes/no)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov